1-6 of 6
obinutuzumab
Close
Sort by
Journal Articles

Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials

Jennifer A. Woyach
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 476–481.
https://doi.org/10.1182/hematology.2019001321
Published: 2019
Journal Articles

Where to start? Upfront therapy for follicular lymphoma in 2018

John P. Leonard, Loretta J. Nastoupil, Christopher R. Flowers
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 185–188.
https://doi.org/10.1182/asheducation-2018.1.185
Published: 2018
Journal Articles

Selecting Frontline Therapy for CLL in 2018

Nitin Jain
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 242–247.
https://doi.org/10.1182/asheducation-2018.1.242
Published: 2018
Journal Articles

How should we sequence and combine novel therapies in CLL?

Matthew S. Davids
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 346–353.
https://doi.org/10.1182/asheducation-2017.1.346
Published: 2017
Journal Articles

Sequencing of chronic lymphocytic leukemia therapies

Jacqueline C. Barrientos
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 128–136.
https://doi.org/10.1182/asheducation-2016.1.128
Published: 2016
Journal Articles

Prognostic markers and standard management of chronic lymphocytic leukemia

Stephan Stilgenbauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 368–377.
https://doi.org/10.1182/asheducation-2015.1.368
Published: 2015